The effects on cognitive function and behavioral problems of topiramate compared to carbamazepine as monotherapy for children with benign rolandic epilepsy

Epilepsia

Volumn 48, Issue 9, 2007, Pages 1716-1723

  Kang, Hoon Chul ^a   Eun, Baik Lin ^b   Wu Lee, Chang ^c   Ku Moon, Han ^d   Kim, Joon Sik ^e   Wook Kim, Dong ^f   Soo Lee, Joon ^g   Young Chae, Kyu ^h   Ho Cha, Byung ⁱ   Sook Suh, Eun ^j   Chae Park, Jung ^k   Lim, Kyunghwa ^a   Hye Ha, Eun ^l   Ho Song, Dong ^g   Dong Kim, Heung ^g  

^a Inje University College of Medicine   (South Korea)

^b Korea University College of Medicine   (South Korea)

^c Wonkwang University   (South Korea)

^d Yeungnam University College of Medicine   (South Korea)

^e Keimyung University School of Medicine   (South Korea)

^f Inje University College of Medicine   (South Korea)

^g Yonsei University College of Medicine   (South Korea)

^h CHA University   (South Korea)

ⁱ Yonsei University Wonju College of Medicine   (South Korea)

^j Soonchunhyang University College of Medicine   (South Korea)

^k Sowha Children s Hospital   (South Korea)

^l Sookmyung Women's University   (South Korea)

more..

Author keywords

Behavioral problems; Benign rolandic epilepsy; Carbamazepine; Cognitive function; Topiramate

Indexed keywords

CARBAMAZEPINE; TOPIRAMATE;

ADOLESCENT; ANHIDROSIS; ANOREXIA; ARTICLE; BEHAVIOR DISORDER; CHILD; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIZZINESS; DRUG DOSE ESCALATION; DRUG DOSE TITRATION; ENURESIS; FATIGUE; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; INCREASED APPETITE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTICENTER STUDY; NEUROPSYCHOLOGICAL TEST; PARESTHESIA; PRIORITY JOURNAL; PSYCHOMOTOR RETARDATION; RANDOMIZED CONTROLLED TRIAL; RASH; ROLANDIC EPILEPSY; SOMNOLENCE;

ADOLESCENT; AGE FACTORS; ANTICONVULSANTS; CARBAMAZEPINE; CHILD; CHILD BEHAVIOR DISORDERS; CHILD, PRESCHOOL; COGNITION DISORDERS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; EPILEPSY, ROLANDIC; FRUCTOSE; HUMANS; NEUROPSYCHOLOGICAL TESTS; PERSONALITY INVENTORY; TREATMENT OUTCOME;

EID: 34548432277     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2007.01160.x     Document Type: Article

References (30)

1. Aldenkamp AP, Baker G, Mulder OG, Chadwick D, Cooper P, Doelman J, Duncan R, Cassmann-Mayer C, de Hann GJ, Jughson C, Hulsman J, Overweg J, Pledger G, Rentmeester TW, Riaz H, Wroe S 2000) A multicenter, randomized clinical study to evaluate the effect on cognitive function of topiramate compared with valproate as add-on therapy to carbamazepine in patients with partial-onset seizures. Epilepsia 41 : 1167 1178.
2. Ben-Menachim E, Henriksen O, Dam M, Schmidt D 1996) Double-blind, placebo-controlled trial of topiramate as add-on therapy in patients with refractory partial seizures. Epilepsia 37 : 539 543.
3. Biton V, Montouris GD, Ritter F, Fiviello JJ, Reife R, Lim P, Pledger G 1999) A randomized, placebl-controlled study of topiramate in primary generalized tonic-clonic seizures. Neurology 52 : 1330 1337.
4. Blum D, Meador K, Biton V, Fakhoury T, Shneker B, Chung S, Mills K, Hammer A, Isojärvi J 2006) Cognitve effects of lamotrigine compared with topiramate in patient with epilepsy. Neurology 67 : 400 406.
5. Edwards KR, Potter DL, Wu SC, Kamin M, Hulihan J 2003) Topiramate in the preventive treatment of episodic migraine: a combined analysis from pilot, double-blind, placebo-controlled trials. CNS Spectr 8 : 428 432.
6. Elterman RD, Glauser TA, Wyllie E, Reife R, Wu SC, Pledger G 1999) A double-blind, randomized trial of topiramate as adjunctive therapy for partial-onset seizures in children. Neurology 52 : 1338 1344.
7. Faught E, Wilder BJ, Ramsay RE, Reife RA, Kramer LD, Pledger GW, Karim RM 1996) Topiramate placebocontrolled dose-ranging trial in refractory partial epilepsy using 200, 400, and 600-mg daily dosages. Neurology 46 : 1684 1690.
8. French JA, Kanner AM, Bautista J, Abou-Khalil B, Browne T, Harden CL, Theodore WH, Bazil C, Stern J, Schachter SC, Bergen D, Hirtz D, Montouris GD, Nespeca M, Gidal BG, Marks WJ Jr., Turk WR, Fischer JH, Bourgeois B, Wilner A, Faught RE Jr., Sachdeo RC, Beydoun A, Glauser TA 2004) Efficacy and tolerability of the new antiepileptic drugs II: Treatment of refractory epilepsy. Neurology 62 : 1261 1273.
9. Fritz N, Hoffmann SGJ, Rademacher M, Elger CE, Helmstaedter C 2005) Efficacy and cognitive side effects of tiagabine and topirmate in patients with epilepsy. Epilepsy Behav 6 : 373 381.
10. Gilliam FG, Veloso F, Bomhof MM, Gazda SK, Biton V, Ter Bruggen JP, Neto W, Bailey C, Pledger G, Wu SC 2003) A dose-comparison trial of topiramate as monotherapy in recently diagnosed partial epilepsy. Neurology 60 : 196 201.
11. Guberman A, Neto W, Gassmann-Mayer C 2002) Low-dose topiramate in adults with treatment-resistant partial-onset seizures. Acta Neurol Scand 106 : 183 189.
12. Kockelmann E, Elger CE, Helmstaedter C 2004) Cognitive profile of topiramate as compared with lamotrigine in epilepsy patients on antiepileptic drug polytherapy: relationships to blood serum levels and comedication. Epilepsy Behav 5 : 716 721.
13. Lee HW, Jung DK, Suh CK, Kwon SH, Park SP 2006) Cognitive effects of low-dose topiramate monotherapy in epilepsy patients: A 1-year follow-up. Epilepsy Behav 8 : 736 741.
14. Lee S, Sziklas V, Andermann F, Farnham S, Risse G, Gustafson M, Gastes J, Penovich P, Al-Asmi A, Bubeau F, Jones-Gotman M 2003) The effects of adjunctive topiramate on cognitive function in patients with epilepsy. Epilepsia 44 : 339 347.
15. Martin R, Kuzniecky R, Ho S, Heterington H, Pan J, Sinclair K, Gilliam F, Faught E 1999) Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults. Neurology 52 : 321 327.
16. Meador KJ 1997) Assessing cognitive effects of a new AED without the bias of practice effects. Epilepsia 38 (Suppl 3 S60.
17. Meador KJ, Loring DE, Huh K, Calagher BB, King DW 1990) Comparative cognitive effects of anticonvulsants. Neurology 40 : 391 394.
18. Meador KJ, Loring DW, Hulihan JF, Kamin M, Karim R 2003) Differential cognitive and behavioral effects of topiramate and valproate. Neurology 60 : 1483 1488.
19. Oh KJ, Hong KE, Lee HL, Ha EH 1997) K-CBCL: Korean-Child Behavior Checklist. ChungAng Aptitude Publishing, Seoul.
20. Park KW, Yoon JR, Park HJ, Park HJ, KKW 1991). Manual for the Korean Education Development Institute-Wechsler Intelligence Scale for Children. Korean Education Development Institute, Seoul.
21. Privitera M, Fincham R, Penry J, Reife R, Kramer L, Pledger G, Karim R 1996) Topiramate placebo controlled dose-ranging trial in refractory partial epilepsy using 600, 800, and 1000-mg daily dosages. Neurology 46 : 1678 1683.
22. Privitera M, Ficker DM, Welty TE 2001) Topiramate. In Wyllie E (Ed) The treatment of epilepsy: principles & practice. Lippincott Williams & Wilkins, Philadelphia, pp. 939 946.
23. Privitera MD, Brodie MJ, Mattson RH, Chadwick DW, Neto W, Wang S 2003) Topiramate, carbamazepine and valproate monotherapy: double-blind comparison in newly diagnosed epilepsy. Acta Neurol Scand 107 : 165 175.
24. Rosenfeld WE, Sachdeo RC, Faught RE, Privitera M 1997) Long-term experience with topiramate as adjunctive therapy and as monotherapy in patients with partial onset seizures: retrospective survey of open-label treatment. Epilepsia 38 (Suppl 1 S34 S36.
25. Sachdeo RC, Reife RA, Lim P, Pledger G 1997) Topiramate monotherapy for partial onset seizures. Epilepsia 38 : 294 300.
26. Sachdeo RC, Glauser TA, Ritter F, Reife R, Lim P, Pledger G 1999) A double-blind, randomized trial of topiramate in Lenoox-Gastaut syndrome. Neurology 52 1882 1887.
27. Sharief M, Viteri C, Ben-Menachem E, Weber W, Reife R, Pledger G, Karim R 1996) Double-blind, placebo-controlled study of topiramate in patients with refractory partial epilepsy. Epilepsy Res 25 217 224.
28. Sillanpää ML. (2001) Carbamazepine and oxcarbazepine. In Wyllie E (Ed) The treatment of epilepsy: principles & practice. Lippincott Williams & Wilkins, Philadelphia, pp. 821 842.
29. Tassinari CA, Michelucci R, Chauvel P, Chodkiewicz J, Shorvon S, Henriksen O, Dam M, Reife R, Pledger G, Karim R 1996) Double-blind, placebo-controlled trial of topiramate (600 mg daily) for the treatment of refractory partial epilepsy. Epilepsia 37 : 763 768.
30. Vermeulen J, Aldenkamp AP 1995) Cognitive side-effects of chronic antiepileptic drug treatment: a review of 25 years of research. Epilepsy Res 22 : 65 95.